This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Soluble insulins

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Replaced by insulin analogues as the quickest acting insulins.

Often known as soluble or ‘regular’ or 'neutral' insulin.

Some features of short-acting or neutral insulins include:

  • peak 2-6 hours after subcutaneous injection
  • tendency to form hexamers in the insulin vials - these dissociate slowly leading to reduction in absorption rate
  • onset of action 30–60 mins
  • peak 2–4 hours
  • in some individuals can have an effect 8-12 hours after administration of injection
  • injected 20-30 minutes before a meal
  • may result in postprandial and nocturnal hypoglycaemia because of long-lasting effects
  • in some patients short-acting insulins remain the optimum quick-acting insulin
  • examples Human Actrapid®, Humulin S®, Insuman® Rapid? (also porcine and bovine equivalents of these)
  • note that some of these insulins are also licensed for use in continuous subcutaneous insulin infusion i.e. insulin pumps (1)

Examples include human actrapid.


  1. MeRec Bulletin 2007;17(4).
  2. Prescriber 2001;12 (14): 43-50

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page